Related Experiment Video
Updated: Jun 19, 2026

Culturing and Measuring Fetal and Newborn Murine Long Bones
Published on: April 26, 2019
Growth factors, inflammatory cytokines and postnatal bone strength in preterm infants
Alon Eliakim1, Dan Nemet, Irfan Ahmad
1Child Health and Sports Center, Pediatric Department, Meir Medical Center, Kfar Saba, Israel. eliakim.alon@clalit.org.il
Insights
Preterm infants
Area of Science:
- Neonatal physiology and bone development
- Pediatric endocrinology and immunology
Background:
- Preterm infants exhibit unique challenges in postnatal bone development.
- Growth factors and inflammatory cytokines play critical roles in bone metabolism.
- Understanding these relationships is crucial for optimizing bone health in vulnerable neonates.
Purpose of the Study:
- To investigate the association between growth factors, inflammatory cytokines, and bone development in preterm infants.
- To determine how serum levels of IGF-I, GHBP, IL-6, and IL-1RA correlate with bone strength progression.
Main Methods:
- Fifty preterm infants (24-32 weeks GA) were monitored weekly for bone strength using quantitative ultrasound (bone speed of sound - SOS).
- Serum samples were analyzed for insulin-like growth factor-I (IGF-I), GH binding protein (GHBP), interleukin-6 (IL-6), and IL-1 receptor antagonist (IL-1RA).
- Infants were categorized into bone gainers and bone losers based on changes in bone SOS.
Main Results:
- Despite overall growth, bone SOS significantly decreased in the cohort.
- Growth factors increased and inflammatory cytokines decreased during follow-up.
- Infants with lower baseline bone SOS and lower IL-6 levels showed improved bone strength (bone gainers).
Conclusions:
- Preterm infants with initially lower bone SOS demonstrate a 'catch-up' growth pattern in bone strength.
- Reduced inflammation, indicated by lower IL-6 levels, is associated with improved bone strength gain in preterm infants.
- These findings highlight the interplay between inflammatory status and skeletal development in neonates.
Aim:
To assess the relationships between growth factors, inflammatory cytokines and postnatal bone development in preterm infants.
Methods:
Fifty premature infants (24-32 weeks gestational age, mean birth weight: 1,024 +/- 50 g) participated in the study. Bone strength was determined weekly by quantitative ultrasound measurements of bone speed of sound (SOS). Blood serum measurements of growth factors included circulating IGF-I and GH binding protein. Measurements of circulating cytokines included the pro-inflammatory mediator interleukin (IL)-6, and the anti-inflammatory mediator IL-1 receptor antagonist. Samples were collected when the preterm infants were stabilized and prior to discharge.
Results:
Despite a significant increase in body weight (from 1,024 +/- 50 to 2,420 +/- 59 g, p < 0.001) and body length (from 35.4 +/- 0.6 to 44.6 +/- 0.4 cm, p < 0.001) there was a significant decrease in bone SOS during the follow-up period. There was a significant increase in growth factors and a decrease in inflammatory cytokines during the follow-up. Participants were divided into preterm infants who increased bone SOS (bone gainers, n = 16, from 2,867 +/- 38 to 2,910 +/- 41 m/sec), or decreased bone SOS (bone losers, n = 34, from 2,967 +/- 33 to 2,818 +/- 28 m/sec) during follow-up. Baseline bone SOS was significantly lower in the bone gainers. Baseline circulating growth factors were higher and inflammatory cytokines lower in the bone gainers; however, only the difference in IL-6 reached statistical significance (6.4 +/- 1.6 versus 10.5 +/- 1.2 pg/ml, in bone gainers and losers, respectively; p < 0.05).
Conclusions:
Preterm infants with lower bone SOS at birth tend to 'catch-up' during early postnatal weeks. Increases in bone strength in preterm infants were associated with reduced inflammatory state as suggested by lower levels of circulating IL-6.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Growth of Cartilage and Bone Tissue
Nature and Nurture
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Bone Remodeling and Repair
Bone Formation by Endochondral Ossification

